52. Gracia-Naya M, Usón-Martín M.; Grupo de Estudio de Neurólogos Aragoneses. Estudio transversal multicéntrico de las consultas externas de Neurología de la Seguridad Social en Aragón. Resultados globales. Rev Neurol 1997; 25:194-9.
53. Láinez JM, Vioque J, Hernández Y, Titus F. Prevalence of migraine in Spain.An assesment of the questionnire’s validity by clinical interview. En: Olesen J,ed. Headache classification and epidemiology. New York: Raven Press, Ltd.; 1994. p. 221-5.
54. Matías-Guiu J, Porta-Etessam J, Mateos V, Díaz-Insa S, Lopez-Gil A, Fernández C; Scientific Committee of the PALM Program. One-year prevalence of migraine in Spain: a nationwide population-based survey. Cephalalgia 2011;31:463-70.
55. Castillo J, Muñoz P, Guitera V,et al.Epidemiology of chronic daily headache in the general population.Headache1999;39:190-96.
56. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004;62:1338-42.
57. Steiner TJ. Lifting the burden: the global campaign against headache. Lancet Neurol 2004;3:204-5.
58. Berg J. Economic evidence in migraine and other headaches: a review. Eur JHealth Econom 2004;5:S43-S54.
59. Smith TR, Nicholson RA, Banks JW. Migraine education improves quality of life in a primary care setting. Headache 2010;50:600-12.
60. Láinez JM. Migraña y calidad de vida. Neurología 1998;13 (Supl 2):1-8.
61. Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain 2005;6:429-40.